Japan Tissue Engineering Co., Ltd. (TYO:7774)

Japan Tissue Engineering Income Statement

Financials in millions JPY. Fiscal year is April - March.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Operating Revenue	1,723	1,648	1,613	1,712	1,535
Other Revenue	732	866	419	391	722
Revenue	2,455	2,514	2,032	2,103	2,257
Revenue Growth (YoY)	-2.35%	23.72%	-3.38%	-6.82%	-2.25%
Cost of Revenue	944	823	896	848	1,101
Gross Profit	1,511	1,691	1,136	1,255	1,156
Selling, General & Admin	1,147	1,057	1,221	1,123	1,084
Research & Development	506	407	573	561	468
Other Operating Expenses	55	59	49	52	52
Operating Expenses	1,749	1,546	1,864	1,753	1,623
Operating Income	-238	145	-728	-498	-467
Interest & Investment Income	2	-	1	2	3
Currency Exchange Gain (Loss)	-	-	-1	-	-
Other Non Operating Income (Expenses)	1	1	2	3	1
EBT Excluding Unusual Items	-235	146	-726	-493	-463
Gain (Loss) on Sale of Assets	-	-	-	-1	-
Asset Writedown	-10	-130	-	-	-
Other Unusual Items	10	130	-	-	-
Pretax Income	-235	146	-726	-494	-463
Income Tax Expense	20	3	3	3	3
Net Income	-255	143	-729	-497	-466
Net Income to Common	-255	143	-729	-497	-466
Shares Outstanding (Basic)	41	41	41	41	41
Shares Outstanding (Diluted)	41	41	41	41	41
EPS (Basic)	-6.28	3.52	-17.95	-12.24	-11.48
EPS (Diluted)	-6.28	3.52	-17.95	-12.24	-11.48
Free Cash Flow	-224	78	-771	-328	-461
Free Cash Flow Per Share	-5.52	1.92	-18.98	-8.08	-11.35
Gross Margin	61.55%	67.26%	55.91%	59.68%	51.22%
Operating Margin	-9.70%	5.77%	-35.83%	-23.68%	-20.69%
Profit Margin	-10.39%	5.69%	-35.88%	-23.63%	-20.65%
Free Cash Flow Margin	-9.12%	3.10%	-37.94%	-15.60%	-20.42%
EBITDA	-80	279	-597	-374	-339
EBITDA Margin	-3.26%	11.10%	-29.38%	-17.78%	-15.02%
D&A For EBITDA	158	134	131	124	128
EBIT	-238	145	-728	-498	-467
EBIT Margin	-9.69%	5.77%	-35.83%	-23.68%	-20.69%
Effective Tax Rate	-	2.05%	-	-	-

Updated Jan 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.